课题基金 / 基金详情

Investigating the role of the immunoproteasome in the efficacy of oncolytic virotherapy against breast cancer

Investigating the role of the immunoproteasome in the efficacy of oncolytic virotherapy against breast cancer
研究免疫蛋白酶体在溶瘤病毒治疗乳腺癌疗效中的作用
批准号：
453483
负责人：
Bourgeois-Daigneault Marie-Claude
金额：
$4.37万
依托单位：
Centre hospitalier de l'Universit de Montral (CHUM)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-03-01 至 2023-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=453483&lang=en
关键词：
Immunotherapy Oncolytic Viruses &Amp

项目摘要

项目成果

Bourgeois-Daigneault Marie-Claude的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Oncolytic viruses (OVs) are viruses that specifically kill cancer cells while leaving normal tissues unharmed. Our recent research has focused on breast cancer: we developed several OV-therapies that greatly improved outcomes and were able to uncover the
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Early Career Award in Cancer: To uncover, understand and exploit the estrogen-oncolytic virus crosstalk to improve therapy
To uncover, understand and exploit the estrogen-oncolytic virus crosstalk to improve therapy
Oncolytic Virus Therapy for the Treatment of Triple Negative Breast Cancer: coupling oncolytic viruses and immunotherapy
  • 批准号：
    318678
  • 项目类别：
    Fellowship Programs
  • 资助金额：
    $8.74万
  • 财政年份：
    2014
  • 负责人：
    Bourgeois-Daigneault Marie-Claude
  • 依托单位：
    Ottawa Hospital Research Institute